Stay updated on Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.

Latest updates to the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision badge updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA new revision tag 'Revision: v3.4.3' appears, replacing the previous 'Revision: v3.4.2'. This is a lightweight update to the page's revision label.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 is now shown and the government funding/status notice has been removed, reflecting administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added, with links to cc.nih.gov and opm.gov. A new site revision tag v3.4.1 was introduced (replacing v3.4.0).SummaryDifference0.4%

- Check68 days agoChange DetectedAdded a glossary toggle and updated QC-related labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), plus minor capitalization changes.SummaryDifference0.2%

- Check104 days agoChange DetectedAdded a Locations section listing District of Columbia, North Carolina, and Pennsylvania sites and updated to Revision: v3.3.3. Removed the previous standalone District of Columbia, North Carolina, and Pennsylvania location entries.SummaryDifference0.4%

Stay in the know with updates to Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.